Precision Optics Corporation, Inc. Common stock (POCI) - Net Assets
Based on the latest financial reports, Precision Optics Corporation, Inc. Common stock (POCI) has net assets worth $20.11 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($33.69 Million) and total liabilities ($13.58 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Precision Optics Corporation, Inc. Commo (POCI) strategic investment index to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $20.11 Million |
| % of Total Assets | 59.69% |
| Annual Growth Rate | 5.8% |
| 5-Year Change | 257.28% |
| 10-Year Change | 1987.78% |
| Growth Volatility | 159.06 |
Precision Optics Corporation, Inc. Common stock - Net Assets Trend (1991–2025)
This chart illustrates how Precision Optics Corporation, Inc. Common stock's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see market cap of Precision Optics Corporation, Inc. Commo.
Annual Net Assets for Precision Optics Corporation, Inc. Common stock (1991–2025)
The table below shows the annual net assets of Precision Optics Corporation, Inc. Common stock from 1991 to 2025. Also explore POCI net assets growth trend to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | $12.26 Million | +21.76% |
| 2024-06-30 | $10.07 Million | -16.43% |
| 2023-06-30 | $12.05 Million | +34.28% |
| 2022-06-30 | $8.97 Million | +161.47% |
| 2021-06-30 | $3.43 Million | +23.79% |
| 2020-06-30 | $2.77 Million | -17.92% |
| 2019-06-30 | $3.38 Million | +498.70% |
| 2018-06-30 | $564.04K | +1.01% |
| 2017-06-30 | $558.38K | -4.90% |
| 2016-06-30 | $587.17K | -11.95% |
| 2015-06-30 | $666.89K | -9.95% |
| 2014-06-30 | $740.58K | -56.70% |
| 2013-06-30 | $1.71 Million | +229.31% |
| 2012-06-30 | $519.33K | +143.47% |
| 2011-06-30 | $-1.19 Million | -627.33% |
| 2010-06-30 | $-164.25K | -134.05% |
| 2009-06-30 | $482.31K | -65.60% |
| 2008-06-30 | $1.40 Million | -39.49% |
| 2007-06-30 | $2.32 Million | -12.22% |
| 2006-06-30 | $2.64 Million | -7.36% |
| 2005-06-30 | $2.85 Million | +89.47% |
| 2004-06-30 | $1.50 Million | -71.01% |
| 2003-06-30 | $5.19 Million | -36.07% |
| 2002-06-30 | $8.12 Million | -55.13% |
| 2001-06-30 | $18.09 Million | -5.98% |
| 2000-06-30 | $19.24 Million | +669.62% |
| 1999-06-30 | $2.50 Million | -39.02% |
| 1998-06-30 | $4.10 Million | -19.61% |
| 1997-06-30 | $5.10 Million | -7.27% |
| 1996-06-30 | $5.50 Million | +7.84% |
| 1995-06-30 | $5.10 Million | +18.60% |
| 1994-06-30 | $4.30 Million | +4.88% |
| 1993-06-30 | $4.10 Million | -22.64% |
| 1992-06-30 | $5.30 Million | +194.44% |
| 1991-06-30 | $1.80 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Precision Optics Corporation, Inc. Common stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 19090.2% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $77.15K | 0.63% |
| Other Components | $69.15 Million | 564.10% |
| Total Equity | $12.26 Million | 100.00% |
Precision Optics Corporation, Inc. Common stock Competitors by Market Cap
The table below lists competitors of Precision Optics Corporation, Inc. Common stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sequana Medical NV
BR:SEQUA
|
$47.76 Million |
|
Senko Co. Ltd
KQ:347000
|
$47.78 Million |
|
Carlos Casado
BA:CADO
|
$47.79 Million |
|
SMCore.Inc
KQ:007820
|
$47.79 Million |
|
IBKS No2 SPAC
KQ:204840
|
$47.72 Million |
|
Rothwell International Co. Limited
KQ:900260
|
$47.70 Million |
|
Mcleod Russel India Limited
NSE:MCLEODRUSS
|
$47.69 Million |
|
Nuveen New York Select Tax-Free Income Portfolio
NYSE:NXN
|
$47.65 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Precision Optics Corporation, Inc. Common stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 10,067,788 to 12,258,834, a change of 2,191,046 (21.8%).
- Net loss of 5,780,246 reduced equity.
- New share issuances of 6,270,136 increased equity.
- Other factors increased equity by 1,701,156.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-5.78 Million | -47.15% |
| Share Issuances | $6.27 Million | +51.15% |
| Other Changes | $1.70 Million | +13.88% |
| Total Change | $- | 21.76% |
Book Value vs Market Value Analysis
This analysis compares Precision Optics Corporation, Inc. Common stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.42x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.02x to 2.42x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1991-06-30 | $189.10 | $4.36 | x |
| 1992-06-30 | $416.70 | $4.36 | x |
| 1993-06-30 | $283.95 | $4.36 | x |
| 1994-06-30 | $387.18 | $4.36 | x |
| 1995-06-30 | $382.51 | $4.36 | x |
| 1996-06-30 | $404.65 | $4.36 | x |
| 1997-06-30 | $383.66 | $4.36 | x |
| 1998-06-30 | $302.45 | $4.36 | x |
| 1999-06-30 | $168.63 | $4.36 | x |
| 2000-06-30 | $1033.11 | $4.36 | x |
| 2001-06-30 | $777.10 | $4.36 | x |
| 2002-06-30 | $347.42 | $4.36 | x |
| 2003-06-30 | $222.09 | $4.36 | x |
| 2004-06-30 | $64.38 | $4.36 | x |
| 2005-06-30 | $31.67 | $4.36 | x |
| 2006-06-30 | $22.58 | $4.36 | x |
| 2007-06-30 | $8.86 | $4.36 | x |
| 2008-06-30 | $4.13 | $4.36 | x |
| 2009-06-30 | $1.42 | $4.36 | x |
| 2010-06-30 | $-0.48 | $4.36 | x |
| 2011-06-30 | $-3.60 | $4.36 | x |
| 2012-06-30 | $1.22 | $4.36 | x |
| 2013-06-30 | $1.46 | $4.36 | x |
| 2014-06-30 | $0.50 | $4.36 | x |
| 2015-06-30 | $0.32 | $4.36 | x |
| 2016-06-30 | $0.25 | $4.36 | x |
| 2017-06-30 | $0.20 | $4.36 | x |
| 2018-06-30 | $0.17 | $4.36 | x |
| 2019-06-30 | $0.88 | $4.36 | x |
| 2020-06-30 | $0.64 | $4.36 | x |
| 2021-06-30 | $0.78 | $4.36 | x |
| 2022-06-30 | $1.69 | $4.36 | x |
| 2023-06-30 | $2.13 | $4.36 | x |
| 2024-06-30 | $1.66 | $4.36 | x |
| 2025-06-30 | $1.81 | $4.36 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Precision Optics Corporation, Inc. Common stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -47.15%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -30.28%
- • Asset Turnover: 0.96x
- • Equity Multiplier: 1.61x
- Recent ROE (-47.15%) is above the historical average (-61.13%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1991 | 11.11% | 4.55% | 1.42x | 1.72x | $20.00K |
| 1992 | -1.89% | -1.72% | 0.97x | 1.13x | $-630.00K |
| 1993 | -31.71% | -27.08% | 0.94x | 1.24x | $-1.71 Million |
| 1995 | 11.76% | 7.89% | 1.25x | 1.20x | $90.00K |
| 1996 | 7.27% | 4.94% | 1.14x | 1.29x | $-150.00K |
| 1997 | -7.84% | -5.41% | 1.23x | 1.18x | $-910.00K |
| 1998 | -48.78% | -48.78% | 0.80x | 1.24x | $-2.41 Million |
| 1999 | -68.00% | -56.67% | 0.91x | 1.32x | $-1.95 Million |
| 2000 | -11.20% | -71.63% | 0.15x | 1.04x | $-4.08 Million |
| 2001 | -20.69% | -88.09% | 0.22x | 1.06x | $-5.55 Million |
| 2002 | -122.89% | -562.11% | 0.20x | 1.09x | $-10.79 Million |
| 2003 | -56.43% | -122.03% | 0.42x | 1.10x | $-3.45 Million |
| 2004 | -244.96% | -251.48% | 0.70x | 1.39x | $-3.83 Million |
| 2005 | -129.43% | -273.25% | 0.40x | 1.18x | $-3.97 Million |
| 2006 | -86.08% | -99.47% | 0.71x | 1.22x | $-2.54 Million |
| 2007 | -124.71% | -116.64% | 0.82x | 1.31x | $-3.12 Million |
| 2008 | -115.78% | -55.93% | 1.27x | 1.63x | $-1.76 Million |
| 2009 | -205.70% | -28.12% | 1.79x | 4.10x | $-1.04 Million |
| 2010 | 0.00% | -21.36% | 1.60x | 0.00x | $-644.46K |
| 2011 | 0.00% | -46.88% | 2.00x | 0.00x | $-933.15K |
| 2012 | 185.04% | 44.65% | 1.73x | 2.40x | $909.04K |
| 2013 | -104.53% | -70.95% | 1.09x | 1.35x | $-1.96 Million |
| 2014 | -156.72% | -31.79% | 1.99x | 2.48x | $-1.23 Million |
| 2015 | -176.76% | -30.13% | 1.92x | 3.06x | $-1.25 Million |
| 2016 | -176.23% | -26.42% | 1.84x | 3.62x | $-1.09 Million |
| 2017 | -180.25% | -31.90% | 1.75x | 3.22x | $-1.06 Million |
| 2018 | -62.30% | -8.70% | 1.61x | 4.45x | $-407.79K |
| 2019 | -18.21% | -9.04% | 0.91x | 2.22x | $-952.56K |
| 2020 | -51.45% | -14.37% | 1.56x | 2.29x | $-1.70 Million |
| 2021 | -3.00% | -0.96% | 1.70x | 1.82x | $-445.95K |
| 2022 | -10.35% | -5.92% | 0.94x | 1.86x | $-1.83 Million |
| 2023 | -1.20% | -0.69% | 1.07x | 1.64x | $-1.35 Million |
| 2024 | -29.32% | -15.45% | 1.13x | 1.68x | $-3.96 Million |
| 2025 | -47.15% | -30.28% | 0.96x | 1.61x | $-7.01 Million |
Industry Comparison
This section compares Precision Optics Corporation, Inc. Common stock's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,000,768,600
- Average return on equity (ROE) among peers: -60.76%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Precision Optics Corporation, Inc. Common stock (POCI) | $20.11 Million | 11.11% | 0.68x | $47.72 Million |
| Akoya Biosciences Inc (AKYA) | $7.59 Million | -728.97% | 15.46x | $64.44 Million |
| Align Technology Inc (ALGN) | $3.23 Billion | 54.92% | 0.49x | $10.72 Billion |
| AngioDynamics Inc (ANGO) | $526.83 Million | -0.23% | 0.50x | $635.28 Million |
| AptarGroup Inc (ATR) | $1.29 Billion | 14.23% | 0.67x | $7.66 Billion |
| AtriCure Inc (ATRC) | $247.34 Million | -14.23% | 1.26x | $2.21 Billion |
| Avinger Inc (AVGR) | $-112.78 Million | 0.00% | 0.00x | $1.52 Million |
| Avantor Inc (AVTR) | $4.86 Billion | 14.14% | 1.77x | $9.19 Billion |
| Azenta Inc (AZTA) | $642.89 Million | 0.69% | 0.21x | $1.46 Billion |
| Baxter International Inc (BAX) | $6.83 Billion | 32.57% | 1.79x | $11.90 Billion |
| Becton Dickinson and Company (BDX) | $2.49 Billion | 19.29% | 1.03x | $48.93 Billion |
About Precision Optics Corporation, Inc. Common stock
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States. The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endosc… Read more